AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35966250 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin (Group B)
Number of subjects: 84
Study 35966250 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Group C)
Number of subjects: 84
Study 34173640 — intervention group
Group type: EXPERIMENTAL
Intervention: Uroflowmetry and post‐void ultrasound bladder scanning in primary care
Number of subjects: 344
Study 34173640 — intervention group
Group type: COMPARATOR
Intervention: Standard care without uroflowmetry and post‐void ultrasound bladder scanning
Number of subjects: 344
Study 32197277 — intervention group
Group type: EXPERIMENTAL
Intervention: Inclisiran (300 mg subcutaneous injections on days 1, 90, 270, and 450)
Number of subjects: 482
Study 32197277 — intervention group
Group type: COMPARATOR
Intervention: Placebo (matching injections on the same schedule)
Number of subjects: 482
Study 32197277 — intervention group
Group type: EXPERIMENTAL
Intervention: Inclisiran (300 mg)
Number of subjects: 482
Study 32197277 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 482
Study 36163867 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibr+Ven
Number of subjects: 211
Study 36163867 — intervention group
Group type: COMPARATOR
Intervention: Clb+O
Number of subjects: 211
Study 36354038 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight-adjusted intermediate-dose low-molecular-weight heparin
Number of subjects: 1110
Study 36354038 — intervention group
Group type: COMPARATOR
Intervention: Fixed low-dose low-molecular-weight heparin
Number of subjects: 1110
Study 32361668 — intervention group
Group type: EXPERIMENTAL
Intervention: Upward Assimilation (UA) manipulation
Number of subjects: 159
Study 32361668 — intervention group
Group type: EXPERIMENTAL
Intervention: Downward Assimilation (DA) manipulation
Number of subjects: 159
Study 32361668 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no manipulation of social comparison)
Number of subjects: 159
Study 34546390 — intervention group
Group type: EXPERIMENTAL
Intervention: Single pre‐incision tranexamic acid bolus of one gram (Group A)
Number of subjects: 61
Study 34546390 — intervention group
Group type: EXPERIMENTAL
Intervention: Double tranexamic acid dose regimen (Group B)
Number of subjects: 61
Study 32057487 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital workflow
Number of subjects: 40
Study 32057487 — intervention group
Group type: COMPARATOR
Intervention: Conventional workflow
Number of subjects: 40
Study 32773484 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal Testing and Treatment (UTT)
Number of subjects: 8747
Study 32773484 — intervention group
Group type: COMPARATOR
Intervention: Arm A (UTT)
Number of subjects: 8747
Study 32773484 — intervention group
Group type: COMPARATOR
Intervention: Arm B (UTT)
Number of subjects: 8747
Study 32773484 — intervention group
Group type: EXPERIMENTAL
Intervention: All arms
Number of subjects: 8747
Study 34057550 — intervention group
Group type: EXPERIMENTAL
Intervention: Dichoptic VR video games, played for 1 hour per week under supervision
Number of subjects: 91
Study 34057550 — intervention group
Group type: EXPERIMENTAL
Intervention: Dichoptic VR video games
Number of subjects: 91
Study 32944790 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (0.80 g/kg)
Number of subjects: 96
Study 32944790 — intervention group
Group type: COMPARATOR
Intervention: Active placebo (0.04 g/kg)
Number of subjects: 96
Study 32944790 — intervention group
Group type: COMPARATOR
Intervention: Non-alcoholic control beverage
Number of subjects: 96
Study 34004189 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular vitamin A 5000 IU 3 times weekly for 4 weeks
Number of subjects: 807
Study 34004189 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 807
Study 32222255 — intervention group
Group type: EXPERIMENTAL
Intervention: Auscultation using a stethoscope
Number of subjects: 60
Study 32222255 — intervention group
Group type: COMPARATOR
Intervention: Umbilical cord palpation
Number of subjects: 60
Study 32222255 — intervention group
Group type: EXPERIMENTAL
Intervention: Both methods (auscultation and palpation)
Number of subjects: 60
Study 36063757 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamma musical-electrical TNS
Number of subjects: 63
Study 36063757 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta musical-electrical TNS
Number of subjects: 63
Study 36063757 — intervention group
Group type: COMPARATOR
Intervention: Sham musical-electrical TNS
Number of subjects: 63
Study 33385184 — intervention group
Group type: EXPERIMENTAL
Intervention: Guava group (GG)
Number of subjects: 399
Study 33385184 — intervention group
Group type: COMPARATOR
Intervention: Banana group (BG)
Number of subjects: 399
Study 33385184 — intervention group
Group type: COMPARATOR
Intervention: Cucumber group (CG)
Number of subjects: 399
Study 35079939 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical entry sclerotomy (Group 1)
Number of subjects: 103
Study 35079939 — intervention group
Group type: COMPARATOR
Intervention: Tunnel entry sclerotomy (Group 2)
Number of subjects: 103
Study 35079939 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 103
Study 32067777 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid
Number of subjects: 240
Study 32067777 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid plus dexpanthenol
Number of subjects: 240
Study 32067777 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic saline
Number of subjects: 240
Study 32067777 — intervention group
Group type: COMPARATOR
Intervention: All treatments
Number of subjects: 240
Study 34411060 — intervention group
Group type: EXPERIMENTAL
Intervention: Droperidol (20 µg/kg)
Number of subjects: 20
Study 34411060 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline (Control)
Number of subjects: 20
Study 34618630 — intervention group
Group type: COMPARATOR
Intervention: Traditional Surgical Attire (TSA)
Number of subjects: 180
Study 34618630 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical Helmet System (SHS)
Number of subjects: 180
Study 34618630 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical Helmet System with Delayed Ventilation (SHS-DV)
Number of subjects: 180
Study 35613378 — intervention group
Group type: EXPERIMENTAL
Intervention: STAIR sequence
Number of subjects: 8
Study 33741234 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared decision-making (SDM) intervention with decision aids (DAs) and decision coaching
Number of subjects: 130
Study 33741234 — intervention group
Group type: COMPARATOR
Intervention: Standard educational materials from a health educator (control group)
Number of subjects: 130
Study 35863553 — intervention group
Group type: EXPERIMENTAL
Intervention: Newly-defined subgroups of type 2 diabetes
Number of subjects: 12738
Study 34167318 — intervention group
Group type: EXPERIMENTAL
Intervention: High-sensitivity cardiac troponin I concentrations at presentation and on serial testing
Number of subjects: 46092
Study 34167318 — intervention group
Group type: EXPERIMENTAL
Intervention: 99th percentile and rule-in thresholds of 64 ng/L and 5-fold upper reference limit
Number of subjects: 46092
Study 34167318 — intervention group
Group type: EXPERIMENTAL
Intervention: Troponin concentration and change in troponin
Number of subjects: 46092
Study 34167318 — intervention group
Group type: EXPERIMENTAL
Intervention: Troponin concentrations at presentation
Number of subjects: 46092
Study 32108686 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal morphine 150 µg
Number of subjects: 61
Study 32108686 — intervention group
Group type: COMPARATOR
Intervention: Intrathecal saline (control)
Number of subjects: 61
Study 34355538 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive vasodilation strategy
Number of subjects: 666
Study 34355538 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 666
Study 35085017 — intervention group
Group type: EXPERIMENTAL
Intervention: Equine-Assisted Activities and Therapies (EAAT) program conducted for 40 min twice a week for 16 weeks (32 lessons)
Number of subjects: 46
Study 35085017 — intervention group
Group type: COMPARATOR
Intervention: Control group (details not specified)
Number of subjects: 46
Study 32050214 — intervention group
Group type: EXPERIMENTAL
Intervention: IC-8 IOL (AcuFocus)
Number of subjects: 38
Study 32050214 — intervention group
Group type: COMPARATOR
Intervention: Symfony IOL (Johnson & Johnson Vision)
Number of subjects: 38
Study 32108889 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Care plus Be Well at Work (BWAW)
Number of subjects: 253
Study 32108889 — intervention group
Group type: COMPARATOR
Intervention: Integrated Care
Number of subjects: 253
Study 36373545 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical fixation followed by mobilization in a walking boot for 6 weeks
Number of subjects: 160
Study 36373545 — intervention group
Group type: COMPARATOR
Intervention: Nonsurgical management in a walking boot for 6 weeks
Number of subjects: 160
Study 32381738 — intervention group
Group type: EXPERIMENTAL
Intervention: Decisional autonomy
Number of subjects: 3867
Study 32381738 — intervention group
Group type: COMPARATOR
Intervention: Paternalistic advice
Number of subjects: 3867
Study 36130191 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-day artemether-lumefantrine (10-dose) regimen
Number of subjects: 177
Study 36130191 — intervention group
Group type: COMPARATOR
Intervention: 3-day artemether-lumefantrine (6-dose) regimen
Number of subjects: 177
Study 36130191 — intervention group
Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 177
Study 33619371 — intervention group
Group type: EXPERIMENTAL
Intervention: Sickle cell trait (HbAS)
Number of subjects: 7453
Study 33619371 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted malaria risk
Number of subjects: 7453
Study 33619371 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention that halves the risk of malaria episodes
Number of subjects: 7453
Study 32025814 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (1200 mg/d) during immobilization and retraining
Number of subjects: 18
Study 32025814 — intervention group
Group type: COMPARATOR
Intervention: Placebo during immobilization and retraining
Number of subjects: 18
Study 32025814 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (1200 mg/d)
Number of subjects: 18
Study 32025814 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 36082313 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraductal removable stent (IRS) group
Number of subjects: 235
Study 36082313 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 235
Study 33452188 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM)
Number of subjects: 100
Study 33452188 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM) with peer support
Number of subjects: 100
Study 33452188 — intervention group
Group type: COMPARATOR
Intervention: Self-Monitoring of Blood Glucose (SMBG)
Number of subjects: 100
Study 35094217 — intervention group
Group type: EXPERIMENTAL
Intervention: BCP intervention program (breastfeed care plus intervention program) with four home visits for breastfeeding support.
Number of subjects: 32
Study 35094217 — intervention group
Group type: COMPARATOR
Intervention: Conventional care (control group).
Number of subjects: 32
Study 35094217 — intervention group
Group type: EXPERIMENTAL
Intervention: BCP intervention program (breastfeed care plus intervention program).
Number of subjects: 32
Study 33314877 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatic exercises plus deep-water running (AEDWR)
Number of subjects: 48
Study 33314877 — intervention group
Group type: COMPARATOR
Intervention: Aquatic exercises only (AE)
Number of subjects: 48
Study 35122575 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily oral PrEP
Number of subjects: 132
Study 35685488 — intervention group
Group type: EXPERIMENTAL
Intervention: New risk-prediction scoring system for sepsis in AP patients
Number of subjects: 1295
Study 35685488 — intervention group
Group type: COMPARATOR
Intervention: Common indicators (SIRS, BISAP, SOFA, qSOFA)
Number of subjects: 1295
Study 32830368 — intervention group
Group type: EXPERIMENTAL
Intervention: Abstinence-optimized treatment (A-OT, n = 276)
Number of subjects: 574
Study 32830368 — intervention group
Group type: COMPARATOR
Intervention: Recommended usual care (RUC, n = 298)
Number of subjects: 574
Study 32830368 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-TQD craving and anhedonia
Number of subjects: 574
Study 36669909 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical decision support tool (electronic alert)
Number of subjects: 420
Study 36669909 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 420
Study 33688908 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care control
Number of subjects: 635
Study 33688908 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma Survivors Outcomes and Support collaborative care intervention
Number of subjects: 635
Study 35233770 — intervention group
Group type: EXPERIMENTAL
Intervention: 36-hour workshop-based couple relationship education program
Number of subjects: 1320
Study 35233770 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 1320
Study 33230628 — intervention group
Group type: EXPERIMENTAL
Intervention: Oropharyngeal aspiration before position change
Number of subjects: 100
Study 33230628 — intervention group
Group type: COMPARATOR
Intervention: Oropharyngeal aspiration as needed (Control)
Number of subjects: 100
Study 35093516 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin plus veliparib with paclitaxel
Number of subjects: 634
Study 35093516 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin with paclitaxel
Number of subjects: 634
Study 32666172 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic prednisone administration
Number of subjects: 0
Study 32666172 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal triamcinolone
Number of subjects: 0
Study 32666172 — intervention group
Group type: EXPERIMENTAL
Intervention: Orally administered isotretinoin
Number of subjects: 0
Study 32666172 — intervention group
Group type: COMPARATOR
Intervention: Combined intravitreal prophylactic approach of 5-fluorouracil and low molecular weight heparin
Number of subjects: 0
Study 32818267 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning algorithm for CAD detection based on facial photos
Number of subjects: 5796
Study 33279182 — intervention group
Group type: EXPERIMENTAL
Intervention: Checkpoint inhibitors
Number of subjects: 0
Study 33279182 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel targets explored in early phase clinical trials
Number of subjects: 0
Study 33279182 — intervention group
Group type: EXPERIMENTAL
Intervention: Current evidence
Number of subjects: 0
Study 35742460 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Risk class
Number of subjects: 464
Study 35742460 — intervention group
Group type: EXPERIMENTAL
Intervention: Paraphernalia Risk class
Number of subjects: 464
Study 35742460 — intervention group
Group type: EXPERIMENTAL
Intervention: High Sex/Moderate Paraphernalia Risk class
Number of subjects: 464
Study 32557346 — intervention group
Group type: EXPERIMENTAL
Intervention: Erlotinib with cow's milk (3.9% fat)
Number of subjects: 38
Study 32557346 — intervention group
Group type: COMPARATOR
Intervention: Erlotinib with water
Number of subjects: 38
Study 32557346 — intervention group
Group type: EXPERIMENTAL
Intervention: Erlotinib with esomeprazole (40 mg once daily 3 hours prior to erlotinib)
Number of subjects: 38
Study 32557346 — intervention group
Group type: COMPARATOR
Intervention: Erlotinib with milk
Number of subjects: 38
Study 32341047 — intervention group
Group type: EXPERIMENTAL
Intervention: TextMe2 (text message‐based prevention programme)
Number of subjects: 246
Study 32341047 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 246
Study 35244043 — intervention group
Group type: EXPERIMENTAL
Intervention: Qinghua Zhixie Decoction
Number of subjects: 464
Study 35244043 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 464
Study 32930659 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational advice intervention
Number of subjects: 154
Study 36518481 — intervention group
Group type: EXPERIMENTAL
Intervention: BCO‐5 (thymoquinone-rich black cumin oil) at a dose of 200 mg/adult/day for 90 days
Number of subjects: 70
Study 33516238 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioavailable turmeric extract (BCM‐95®) 500 mg capsule two times daily
Number of subjects: 144
Study 33516238 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol 650 mg tablet three times daily
Number of subjects: 144
Study 33516238 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioavailable turmeric extract (BCM‐95®)
Number of subjects: 144
Study 33516238 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol
Number of subjects: 144
Study 33768779 — intervention group
Group type: EXPERIMENTAL
Intervention: Training monitoring based on intensities around critical velocity (95, 100, 105 and 110% of CV)
Number of subjects: 20
Study 33768779 — intervention group
Group type: COMPARATOR
Intervention: Different heart rate (HR) zones (EN1+, EN2, EN2+ and EN3)
Number of subjects: 20
Study 32369199 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 220
Study 32369199 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 220
Study 32816874 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide 2 mg QW plus dapagliflozin 10 mg
Number of subjects: 695
Study 32816874 — intervention group
Group type: COMPARATOR
Intervention: Exenatide QW plus placebo
Number of subjects: 695
Study 32816874 — intervention group
Group type: COMPARATOR
Intervention: Dapagliflozin plus placebo
Number of subjects: 695
Study 32816874 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide QW plus dapagliflozin
Number of subjects: 695
Study 32877616 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body vibration (WBV) training, thrice weekly for 6 months
Number of subjects: 77
Study 32877616 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 77
Study 32749890 — intervention group
Group type: EXPERIMENTAL
Intervention: AT + S
Number of subjects: 60
Study 32749890 — intervention group
Group type: EXPERIMENTAL
Intervention: S
Number of subjects: 60
Study 32749890 — intervention group
Group type: EXPERIMENTAL
Intervention: AT
Number of subjects: 60
Study 32749890 — intervention group
Group type: COMPARATOR
Intervention: C + placebo
Number of subjects: 60
Study 32749890 — intervention group
Group type: EXPERIMENTAL
Intervention: AT + placebo
Number of subjects: 60
Study 36121338 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual diaphragm release plus inspiratory muscle training
Number of subjects: 52
Study 36121338 — intervention group
Group type: COMPARATOR
Intervention: Inspiratory muscle training only
Number of subjects: 52
Study 34343059 — intervention group
Group type: EXPERIMENTAL
Intervention: AI approaches for peptide-based drug discovery
Number of subjects: 0
Study 34343059 — intervention group
Group type: EXPERIMENTAL
Intervention: AI-dependent prediction tools
Number of subjects: 0
Study 33068133 — intervention group
Group type: EXPERIMENTAL
Intervention: Antepartum tactile imaging (ATI) probe examination
Number of subjects: 20
Study 32006612 — intervention group
Group type: EXPERIMENTAL
Intervention: One or three breathlessness training sessions
Number of subjects: 158
Study 35442486 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-lipoic acid (ALA) 600 mg once daily
Number of subjects: 60
Study 35442486 — intervention group
Group type: COMPARATOR
Intervention: Epoetin-alpha plus insulin therapy (Control)
Number of subjects: 60
Study 34231802 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased distraction (intervention)
Number of subjects: 125
Study 34231802 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive care unit bed availability (scarcity)
Number of subjects: 125
Study 34231802 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased intensive care unit admission of vignettes inappropriate for intensive care unit admission in the distractor (intervention) arm
Number of subjects: 125
Study 34231802 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple choices
Number of subjects: 125
Study 34231802 — intervention group
Group type: COMPARATOR
Intervention: Control group (no increased distraction)
Number of subjects: 125
Study 35090520 — intervention group
Group type: EXPERIMENTAL
Intervention: Dulce Digital
Number of subjects: 414
Study 35090520 — intervention group
Group type: EXPERIMENTAL
Intervention: Dulce Digital‐Me‐Automated
Number of subjects: 414
Study 35090520 — intervention group
Group type: EXPERIMENTAL
Intervention: Dulce Digital‐Me‐Telephonic
Number of subjects: 414
Study 35090520 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 414
Study 34702869 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-based motion analysis (CTMA)
Number of subjects: 10
Study 33896814 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping
Number of subjects: 104
Study 33896814 — intervention group
Group type: COMPARATOR
Intervention: Placebo material
Number of subjects: 104
Study 33829706 — intervention group
Group type: EXPERIMENTAL
Intervention: Geometric deep learning model trained on right brain surface meshes with 6,000 faces
Number of subjects: 159
Study 33829706 — intervention group
Group type: COMPARATOR
Intervention: Healthy older adults (control group)
Number of subjects: 159
Study 33084082 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized trauma cue
Number of subjects: 611
Study 33084082 — intervention group
Group type: COMPARATOR
Intervention: Neutral cue
Number of subjects: 611
Study 32693185 — intervention group
Group type: EXPERIMENTAL
Intervention: Tradipitant 85 mg
Number of subjects: 152
Study 32693185 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 152
Study 33032622 — intervention group
Group type: EXPERIMENTAL
Intervention: UCLA Multidimensional Condom Attitudes Scale (MCAS)
Number of subjects: 500
Study 34535615 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-collected cervicovaginal brush samples for HPV testing
Number of subjects: 329
Study 35010932 — intervention group
Group type: EXPERIMENTAL
Intervention: Moringa oleifera (MO) supplementation (2400 mg/day, 6 capsules daily)
Number of subjects: 65
Study 35010932 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLC)
Number of subjects: 65
Study 35320999 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical nursing pathway intervention
Number of subjects: 170